Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UUL | Ann: Removal from Official List - Annual Listing Fees | 04/07/24 | 5 | 2.8K | |||
|
|||||||
UUL | Ann: Suspension from Official Quotation - Annual Listing Fees | 22/08/23 | 0 | 353 | |||
|
|||||||
UUL | Ann: Update on Liquidation | 19/08/23 | 2 | 1.6K | |||
|
|||||||
UUL | Ann: Suspension Update & Response to ASX Query | 13/06/23 | 32 | 13K | |||
|
|||||||
UUL | Ann: Appointment of Liquidators | 17/04/23 | 3 | 1.5K | |||
|
|||||||
UUL | News: UUL Ultima United Says It Appointed Joint & Several Liquidators Of Co | 14/04/23 | 0 | 318 | |||
|
|||||||
UUL | Ann: Market Update | 03/04/23 | 2 | 1.4K | |||
|
|||||||
UUL | News: UUL Ultima United Says Smallcap Corporate Began Proceedings Seeking Orders For UUL To Be... | 29/03/23 | 0 | 353 | |||
|
See All Discussions